Novartis India Adjusts Evaluation Amid Mixed Technical Indicators and Valuation Concerns
Novartis India has recently experienced a change in its evaluation, reflecting a shift in technical trends. The stock's performance metrics indicate a slight decline in price, with a year-over-year return of -4.45%. The company shows strong operating profit growth, but its valuation appears high compared to peers.
Novartis India, a player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in its evaluation. This revision reflects a shift in technical trends, moving from a sideways pattern to a mildly bullish stance. The technical indicators present a mixed picture; while the MACD shows bullish signals on a weekly basis, it leans mildly bearish on a monthly scale. The Relative Strength Index (RSI) indicates bearish conditions weekly, with no significant signals monthly. The stock's performance metrics reveal a current price of 1051.20, slightly down from the previous close of 1052.10. Over the past year, Novartis India has generated a return of -4.45%, contrasting with a profit increase of 18.4%. The company maintains a low Debt to Equity ratio and has demonstrated robust growth in operating profit, averaging an annual rate of 141.64%.
Despite its small-cap status, domestic mutual funds hold a minimal stake in the company, which may suggest caution regarding its current valuation. The stock trades at a premium compared to its peers, with a Price to Book Value of 3.6, indicating a potentially expensive valuation relative to historical averages.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
